Poul Sørensen

Company: Allero Therapeutics

Job title: Professor, Chief Scientific Officer & Co-Founder

Seminars:

Harnessing the Oral Mucosa for Antigen-Specific Immunotherapy of Immune Disorders 9:30 am

SOMIT is a novel non-invasive oral patch approach leveraging the immune privilege of the oral cavity A short-course treatment regimen is achieved by combining prolonged oromucosal antigen presentation with tolerogenic microparticles derived from probiotic bacteria SOMIT is a platfom technology applicable to a wide range of immune disorders e.g. autoimmune, ADA, and allergiesRead more

day: Day Two